Cinacalcet HCl: Clinical Trials

6 trials of Cinacalcet HCl, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 4 Phase 3, 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 1, Unknown 1
Phase 22Terminated 1, Unknown 1
Phase 11Terminated 1
Phase 41Completed 1

Follow Cinacalcet HCl: new trials by email Literature Review of Cinacalcet HCl trials Research Report on Cinacalcet HCl

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Cinacalcet HCl - Hyperparathyroidism; Secondary, Renal
Phase 4CompletedKyowa Kirin China Pharmaceutical Co., Ltd.7502017-04-192024-04-29
Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
Cinacalcet HCl, Standard of Care - Chronic Kidney Disease, Secondary Hyperparathyroidism
Phase 3TerminatedAmgen552014-11-072020-06-29
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Cinacalcet HCl - Parathyroid Carcinoma, Hypercalcemia
Phase 3CompletedKyowa Kirin Co., Ltd.2011-11-012017-03-03
Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
Cinacalcet HCl - Secondary Hyperparathyroidism
Phase 2 / Phase 3UnknownENRICO VERRINA302010-03-012011-11-24
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
Cinacalcet HCl - Secondary Hyperparathyroidism, Hypercalcemia
Phase 1 / Phase 2TerminatedMontefiore Medical Center42007-02-092025-04-29
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Cinacalcet HCl - Kidney Disease, Chronic Kidney Disease
Phase 3CompletedAmgen4002004-10-012013-05-08

Conditions studied

Hyperparathyroidism, Secondary (4)  ·  Renal Insufficiency, Chronic (3)  ·  Hypercalcemia (2)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Hyperparathyroidism (1)  ·  Hyperparathyroidism, Primary (1)  ·  Kidney Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Parathyroid Neoplasms (1)

Sponsors

Amgen (2)  ·  ENRICO VERRINA (1)  ·  Kyowa Kirin China Pharmaceutical Co., Ltd. (1)  ·  Kyowa Kirin Co., Ltd. (1)  ·  Montefiore Medical Center (1)

Countries

Italy (2)  ·  United States (2)  ·  Belgium (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Japan (1)  ·  Lithuania (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Aihua Zhang (1)  ·  Aili Jiang (1)  ·  Chaosheng Chen (1)  ·  Enrico E. Verrina, MD (1)  ·  Guanqing Xiao (1)  ·  Guohua Ding (1)  ·  Hong Liu (1)  ·  Jianming Ye (1)  ·  Jianying Niu (1)  ·  Jiazhuang Lou (1)  ·  Jing Chen (1)  ·  Junwei Yang (1)  ·  Li Hao (1)  ·  Li Zuo (1)

Results publications

PMID 19110359, PMID 23222688

NIH funding

2009 (1)